Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting enzymes involved in inflammatory diseases and cancer. Its structure supports binding to specific protein sites, enhancing selectivity and potency in drug candidates. Also explored in the synthesis of novel bioactive molecules for neurological disorders due to its ability to cross the blood-brain barrier. Commonly employed in structure-activity relationship (SAR) studies to optimize therapeutic efficacy and reduce off-target effects.